Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-003705
Filing Date
2025-05-15
Accepted
2025-05-15 16:08:54
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 actuate_i10q-033125.htm   iXBRL 10-Q 623030
2 TENTH AMENDMENT TO EMPLOYMENT AGREEMENT actuate_ex1003.htm EX-10.3 16388
3 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT actuate_ex1004.htm EX-10.4 12680
4 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT actuate_ex1005.htm EX-10.5 15534
5 CERTIFICATION actuate_ex3101.htm EX-31.1 7686
6 CERTIFICATION actuate_ex3102.htm EX-31.2 7724
7 CERTIFICATION actuate_ex3201.htm EX-32.1 6532
13 GRAPHIC image_001.jpg GRAPHIC 1340
  Complete submission text file 0001683168-25-003705.txt   3485132

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE actu-20250331.xsd EX-101.SCH 33269
9 XBRL CALCULATION FILE actu-20250331_cal.xml EX-101.CAL 38970
10 XBRL DEFINITION FILE actu-20250331_def.xml EX-101.DEF 118047
11 XBRL LABEL FILE actu-20250331_lab.xml EX-101.LAB 226367
12 XBRL PRESENTATION FILE actu-20250331_pre.xml EX-101.PRE 206430
68 EXTRACTED XBRL INSTANCE DOCUMENT actuate_i10q-033125_htm.xml XML 380249
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42139 | Film No.: 25952955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)